Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Hims & Hers Health (HIMS) stock in plain English

Free brief · no signupStart here
HIMSPublished Nov 7, 2026
Hims & Hers Health Inc
Healthcare · Drug Manufacturers - Specialty & Generic
Operates a digital health platform connecting patients with licensed healthcare professionals.
Assets:
50-state pharmacy networkAffiliated compounding facilities and outsourcing partner MedisourceRx.
Licensed provider networkThousands of contracted medical clinicians managing digital patient consultations.
2+ million active subscribersRecurring consumer accounts ordering customized health and wellness products.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

27
OPS ScoreOperating finances
Latest quote
-6.04%$16.02
$3.76B
n/a (loss)
$2.87B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 07, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was HIMS. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Hims & Hers Health (HIMS) do?

Hims & Hers Health Inc (HIMS) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Operates a digital health platform connecting patients with licensed healthcare professionals. Sells direct-to-consumer telehealth consultations and personalized prescription treatments through a proprietary online. It is worth $3.76B on the market and sold $2.87B over the last year.

Market cap
$3.76B
P/E ratio
None (reported a loss)
Annual sales
$2.87B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Brief updated
Nov 07, 2026

Brands and businesses behind HIMS

  • Hims: Sells men's personalized prescription treatments and wellness products through an online direct-to-consumer subscription model.
  • Hers: Sells women's specialized healthcare, dermatology, and wellness prescriptions through an online subscription platform.
  • Apostrophe: Provides custom prescription skincare treatments formulated by dermatologists and delivered via direct subscription orders.

HIMS’s flags, in plain English

Each flag is a number from Hims & Hers Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 07, 2026.

Still Climbing

Sales up 73.6% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Wide Gross Margin

Gross margin of 50% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Insiders Hold

Insiders own 9.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.

Debt Is Driving

Heavy debt, 439% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.

2 more risk notes open with the free trial. Try it free for 7 days.

Questions about HIMS

How big is Hims & Hers Health?

Hims & Hers Health’s market cap is $3.76B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.87B: what customers paid the company over the last year, before any costs.

What is HIMS’s P/E ratio?

HIMS has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.

What could go wrong with HIMS?

FDA regulatory scrutiny of compounded GLP-1 weight-loss medications poses a direct threat to high-growth product offerings. That is one risk on Hims & Hers Health’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Hims & Hers Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. HIMS’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card